Hai-Yan Li, Xiu-Ying Cui, and Wei Wu contributed equally to this work.
Pyk2 and Src Mediate Signaling to CCL18-Induced Breast Cancer Metastasis
Version of Record online: 19 JAN 2014
© 2013 Wiley Periodicals, Inc.
Journal of Cellular Biochemistry
Volume 115, Issue 3, pages 596–603, March 2014
How to Cite
Li, H.-Y., Cui, X.-Y., Wu, W., Yu, F.-Y., Yao, H.-R., Liu, Q., Song, E.-W. and Chen, J.-Q. (2014), Pyk2 and Src Mediate Signaling to CCL18-Induced Breast Cancer Metastasis. J. Cell. Biochem., 115: 596–603. doi: 10.1002/jcb.24697
- Issue online: 19 JAN 2014
- Version of Record online: 19 JAN 2014
- Accepted manuscript online: 19 OCT 2013 02:35AM EST
- Manuscript Accepted: 14 OCT 2013
- Manuscript Received: 4 SEP 2013
- 973 Projects from the Ministry of Science and Technology of China. Grant Numbers: 2010CB912800, 2011CB504203
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|jcb24697-sm-0001-SupFig-S1.tif||2173K||Fig. S1. The efficiencies of Pyk2-siRNAs and Src-siRNAs. A: Two Pyk2-siRNAs that efficiently reduced the mRNA and protein expression levels of Pyk2. MDA-MB-231 cells were untransfected, mock-transfected or transfected with GFP-siRNA or three of the Pyk2-siRNAs for 24 or 48 h. mRNA and proteins were extracted for RT-PCR and Western blot experiments as indicated. B: Similar to (A), two Src-siRNAs that efficiently reduced the mRNA and protein expression of Src.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.